Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study | Zendy

Belén GutiérrezGutiérrez | Zendy; Robert A. Bonomo | Zendy; Yehuda Carmeli | Zendy; David L. Paterson | Zendy; Benito Almirante | Zendy; Luis MartínezMartínez | Zendy; Antonio Oliver | Zendy; Esther Calbo | Zendy; Carmen Peña | Zendy; Murat Akova | Zendy; Johann Pitout | Zendy; Julia Origüen | Zendy; Vicente Pintado | Zendy; Elisa GarcíaVázquez | Zendy; Oriol Gasch | Zendy; Axel Hamprecht | Zendy; Núria Prim | Zendy; Mario Tumbarello | Zendy; Germán Bou | Zendy; Pierluigi Viale | Zendy; Evelina Tacconelli | Zendy; Manel Almela | Zendy; Federico Pérez | Zendy; Helen Giamarellou | Zendy; José Miguel Cisneros | Zendy; Mitchell J. Schwaber | Zendy; Mario Venditti | Zendy; Warren Lowman | Zendy; Joaquín Bermejo | Zendy; PoRen Hsueh | Zendy; Marta Mora-Rillo | Zendy; Irene Gracia-Ahulfinger | Zendy; Álvaro Pascual | Zendy; Jesús RodríguezBaño | Zendy

Open Access

Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study

Author(s) -

Belén GutiérrezGutiérrez,

Robert A. Bonomo,

Yehuda Carmeli,

David L. Paterson,

Benito Almirante,

Luis MartínezMartínez,

Antonio Oliver,

Esther Calbo,

Carmen Peña,

Murat Akova,

Johann Pitout,

Julia Origüen,

Vicente Pintado,

Elisa GarcíaVázquez,

Oriol Gasch,

Axel Hamprecht,

Núria Prim,

Mario Tumbarello,

Germán Bou,

Pierluigi Viale,

Evelina Tacconelli,

Manel Almela,

Federico Pérez,

Helen Giamarellou,

José Miguel Cisneros,

Mitchell J. Schwaber,

Mario Venditti,

Warren Lowman,

Joaquín Bermejo,

PoRen Hsueh,

Marta Mora-Rillo,

Irene Gracia-Ahulfinger,

Álvaro Pascual,

Jesús RodríguezBaño

Publication year - 2016

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkv502

Subject(s) - ertapenem , medicine , propensity score matching , carbapenem , retrospective cohort study , bacteremia , mortality rate , cohort , microbiology and biotechnology , antibiotics , meropenem , antibiotic resistance , biology

Data about the efficacy of ertapenem for the treatment of bloodstream infections (BSI) due to ESBL-producing Enterobacteriaceae (ESBL-E) are limited. We compared the clinical efficacy of ertapenem and other carbapenems in monomicrobial BSI due to ESBL-E.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research